{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:15:01Z","timestamp":1792275301678,"version":"4.4.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Association between the apolipoprotein L1 gene (<jats:italic toggle=\"yes\">APOL1<\/jats:italic>) and nephropathy has altered the epidemiology of chronic kidney disease. In addition, donor <jats:italic toggle=\"yes\">APOL1<\/jats:italic> genotypes play important roles in the time to allograft failure in kidneys transplanted from deceased donors and the safety of living kidney donation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This article reviews genetic testing for inherited kidney disease in living kidney donors to improve donor safety. <jats:italic toggle=\"yes\">APOL1<\/jats:italic> genotyping in donors with recent African ancestry is considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Based on current data, transplant physicians should discuss <jats:italic toggle=\"yes\">APOL1<\/jats:italic> genotyping with potential living kidney donors self-reporting recent African ancestry. Until results from <jats:italic toggle=\"yes\">APOL1<\/jats:italic> Long-term Kidney Transplant Outcomes Network ancillary studies are available, we present practical approaches from our experience for considering <jats:italic toggle=\"yes\">APOL1<\/jats:italic> genotyping in the living donor evaluation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Transplant physicians should inform potential living kidney donors at risk for <jats:italic toggle=\"yes\">APOL1<\/jats:italic>-associated nephropathy about the gene and possibility of genetic testing early in the donor evaluation, well before scheduling the donor nephrectomy. Transplant programs must weigh risks of performing a donor nephrectomy in those with 2 <jats:italic toggle=\"yes\">APOL1<\/jats:italic> renal risk variants (high-risk genotypes), particularly younger individuals. Our program counsels kidney donors with <jats:italic toggle=\"yes\">APOL1<\/jats:italic> high-risk genotypes in the same fashion as with risk genotypes in other nephropathy genes. Because most African American kidney donor candidates lacking hypertension, proteinuria and reduced kidney function after workup will not possess <jats:italic toggle=\"yes\">APOL1<\/jats:italic> high-risk genotypes, genetic testing is unlikely to markedly increase donor declines and may reassure donors with regard to their long-term kidney outcomes, potentially increasing the number of African American donors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002933","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T13:34:04Z","timestamp":1566653644000},"page":"27-32","source":"Crossref","is-referenced-by-count":32,"title":["Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation"],"prefix":"10.1097","volume":"104","author":[{"given":"Alejandra M.","family":"Mena-Gutierrez","sequence":"first","affiliation":[{"name":"Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber M.","family":"Reeves-Daniel","sequence":"additional","affiliation":[{"name":"Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen L.","family":"Jay","sequence":"additional","affiliation":[{"name":"Department of Surgery, Wake Forest School of Medicine, Winston-Salem, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Freedman","sequence":"additional","affiliation":[{"name":"Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation.","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2215\/CJN.11220918","article-title":"Risks of living kidney donation: current state of knowledge on outcomes important to donors.","volume":"14","author":"Lentine","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/TP.0000000000001770","article-title":"Summary of Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors.","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ekir.2019.03.006","article-title":"APOL1-associated kidney disease in Brazil.","volume":"4","author":"Riella","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans.","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2013.12.014","article-title":"APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.","volume":"63","author":"Kofman","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation.","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.","volume":"15","author":"Freedman","year":"2015","journal-title":"Am J Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors.","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of black living donors.","volume":"29","author":"Doshi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/TP.0b013e31822eec39","article-title":"African American living-kidney donors should be screened for APOL1 risk alleles.","volume":"92","author":"Cohen","year":"2011","journal-title":"Transplantation"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/ajt.14173","article-title":"Integrating APOL1 gene variants into renal transplantation: considerations arising from the American Society of Transplantation Expert Conference.","volume":"17","author":"Newell","year":"2017","journal-title":"Am J Transplant"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2015.04.046","article-title":"Testing for high-risk APOL1 alleles in potential living kidney donors.","volume":"66","author":"Riella","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1681\/ASN.2018111091","article-title":"You are just now telling us about this? African American perspectives of testing for genetic susceptibility to kidney disease.","volume":"30","author":"Umeukeje","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jama.2017.19617","article-title":"Disparities in live donor kidney transplantation: related to poverty, race, or ethnicity?","volume":"319","author":"Jay","year":"2018","journal-title":"JAMA"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ajt.13970","article-title":"Screening of living kidney donors for genetic diseases using a comprehensive genetic testing strategy.","volume":"17","author":"Thomas","year":"2017","journal-title":"Am J Transplant"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/TP.0000000000000733","article-title":"Race, relationship and renal diagnoses after living kidney donation.","volume":"99","author":"Lentine","year":"2015","journal-title":"Transplantation"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","article-title":"Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.","volume":"92","author":"Allen","year":"2017","journal-title":"Kidney Int"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate.","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among living kidney donors.","volume":"363","author":"Lentine","year":"2010","journal-title":"N Engl J Med"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.02510213","article-title":"The modern spectrum of renal biopsy findings in patients with diabetes.","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2215\/CJN.08310817","article-title":"Need to reclassify etiologies of ESRD on the CMS 2728 medical evidence report.","volume":"13","author":"Tucker","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R25-20231002","first-page":"1170","article-title":"Diagnostic clinical genome and exome sequencing.","volume":"371","author":"Biesecker","year":"2014","journal-title":"N Engl J Med"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.2014.48","article-title":"Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing.","volume":"85","author":"Brown","year":"2014","journal-title":"Kidney Int"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2215\/CJN.07200712","article-title":"Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome.","volume":"8","author":"McCarthy","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2011101032","article-title":"Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.","volume":"23","author":"Rossetti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/TP.0000000000000466","article-title":"Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease.","volume":"99","author":"Simms","year":"2015","journal-title":"Transplantation"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/TP.0b013e318191e729","article-title":"DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.","volume":"87","author":"Huang","year":"2009","journal-title":"Transplantation"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease.","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2013a KDIGO consensus report.","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy.","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group.","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1600-6143.2011.03609.x","article-title":"Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation.","volume":"11","author":"Cherikh","year":"2011","journal-title":"Am J Transplant"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.14678","article-title":"Risk of ESRD in prior living kidney donors.","volume":"18","author":"Wainright","year":"2018","journal-title":"Am J Transplant"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0272-6386(12)80266-6","article-title":"The familial risk of end-stage renal disease in African Americans.","volume":"21","author":"Freedman","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/ajt.13827","article-title":"Health insurance trends in United States living kidney donors (2004 to 2015).","volume":"16","author":"Rodrigue","year":"2016","journal-title":"Am J Transplant"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.","volume":"9","author":"Freedman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.2018020137","article-title":"Evaluation of potential living kidney donors in the APOL1 era.","volume":"29","author":"Freedman","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"R42-20231002","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.nephro.2019.02.005","article-title":"APOL1 risk genotype in Europe: data in patients with focal segmental glomerulosclerosis and after renal transplantation.","volume":"15","author":"Servais","year":"2019","journal-title":"Nephrol Ther"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/ajt.14035","article-title":"APOL1-associated end-stage renal disease in a living kidney transplant donor.","volume":"16","author":"Zwang","year":"2016","journal-title":"Am J Transplant"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/ajt.14113","article-title":"Effect of replacing race with apolipoprotein L1 genotype in calculation of kidney donor risk index.","volume":"17","author":"Julian","year":"2017","journal-title":"Am J Transplant"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.01510218","article-title":"The APOL1 Long-term Kidney Transplantation Outcomes Network-APOLLO.","volume":"13","author":"Freedman","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semnephrol.2017.07.009","article-title":"Clinical genetic testing for APOL1: are we there yet?","volume":"37","author":"Young","year":"2017","journal-title":"Semin Nephrol"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1526924816654608","article-title":"Introducing genetic tests with uncertain implications in living donor kidney transplantation: apol1 as a case study.","volume":"26","author":"Ross","year":"2016","journal-title":"Prog Transplant"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in blacks.","volume":"28","author":"Naik","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfr522","article-title":"Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.","volume":"27","author":"Cooke","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R50-20231002","article-title":"APOL1 genetic testing in living kidney transplant donors.","author":"Mohan","journal-title":"Am J Kidney Dis"},{"key":"R51-20231002","article-title":"A National Survey of Transplant Surgeons and Nephrologists on Implementing Apolipoprotein L1 (APOL1) Genetic Testing Into Clinical Practice.","author":"Gordon","journal-title":"Prog Transplant"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.ajkd.2018.07.017","article-title":"African American living donors\u2019 attitudes about APOL1 genetic testing: a mixed methods study.","volume":"72","author":"Gordon","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000356244","article-title":"Perceptions regarding genetic testing in populations at risk for nephropathy.","volume":"38","author":"Freedman","year":"2013","journal-title":"Am J Nephrol"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/ajt.15368","article-title":"The changing landscape of live kidney donation in the United States from 2005 to 2017.","volume":"19","author":"Al Ammary","year":"2019","journal-title":"Am J Transplant"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"126124","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-gamma-induced proteinuria in APOL1-transgenic mice.","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:04:45Z","timestamp":1696223085000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002933","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}